日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Second-line nab-paclitaxel and gemcitabine for advanced pancreatic cancer following FOLFIRINOX: outcomes and insights

FOLFIRINOX方案治疗后晚期胰腺癌的二线治疗:白蛋白结合型紫杉醇联合吉西他滨:结果与启示

Merc Cetınkaya, Aysegul; Tatlı, Ali Murat; Goktas Aydın, Sabin; Kılıckap, Saadettin; Bılıcı, Ahmet; Bırıcık, Fatih Selçuk; Kostek, Osman; Kayıkcıoglu, Erkan; Paydas, Semra; Artac, Mehmet; Teker, Fatih; Cıl, Timucin; Kaplan, Muhammed Ali; Hacıbekıroglu, İlhan; Geredelı, Caglayan; Bayram, Ertugrul; Altıntas, Yunus Emre; Celebı, A Samed; Kocak, Mehmed Zahid; Arak, Haci; Arslan Benlı, Burcu; Arvas, Hayati; Dınc Sonusen, Sermin; Sezgın Goksu, Sema